
Study Period | 2020 - 2030 |
Base Year For Estimation | 2024 |
Forecast Data Period | 2025 - 2030 |
Market Size (2025) | USD 1.33 Billion |
Market Size (2030) | USD 1.73 Billion |
CAGR (2025 - 2030) | 5.35 % |
Market Concentration | Medium |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Europe Urinary Catheters Market Analysis
The Europe Urinary Catheters Market size is estimated at USD 1.33 billion in 2025, and is expected to reach USD 1.73 billion by 2030, at a CAGR of 5.35% during the forecast period (2025-2030).
Factors such as the rising burden of urinary tract-related infections and other diseases and the growing geriatric population are expected to drive market growth in Europe over the forecast period.
In Europe, urinary incontinence among women represents a significant health concern, primarily attributed to pregnancy and vaginal births.
A December 2024 article published in the International Journal of Obstetrics & Gynaecology detailed a comprehensive study conducted by researchers from the United Kingdom and Finland. The study examined pelvic floor dysfunction (PFD), which includes urinary incontinence (UI), faecal incontinence (FI), and prolapse over a period exceeding 20 years following childbirth. The findings indicated a consistent increase in the prevalence of PFD for up to 26 years after the initial birth, with substantial differences observed based on the mode of delivery.
Notably, exclusive cesarean sections (CS) were associated with a significantly lower risk of developing UI, FI, and prolapse symptoms, underscoring the potential long-term impact of delivery methods on women's health outcomes. Urinary incontinence following pregnancy is a significant health concern that drives the increasing demand for urinary catheters. This growing demand is anticipated to play a pivotal role in propelling the market's expansion during the forecast period.
Furthermore, an increase in clinical studies to evaluate the efficacy of urinary catheters and the strategic activities of the key players are further expected to bolster the market growth over the forecast period. For instance, a January 2024 article in Scientific Reports detailed groundbreaking research conducted in Denmark, where scientists developed a novel micro-hole zone catheter (MHZC). This catheter was rigorously tested in both ex vivo porcine models and live pigs, demonstrating superior performance compared to the conventional catheter (CEC) by achieving higher flow rates and significantly reducing residual volumes.
Furthermore, the market is poised for growth, bolstered by the endorsement of cutting-edge catheters in treating urinary infections. For example, in January 2023, after a thorough authorization process, Bactiguard secured its inaugural MDR (Medical Device Regulations 2017/745) product approval. This MDR nod was granted for Bactiguard's latex BIP Foley Catheter, a specialized indwelling urinary catheter boasting a distinctive infection prevention technology. Such regulatory approvals not only validate the technological advancements of these products but also enhance their marketability, driving adoption rates among healthcare providers. This trend is expected to significantly contribute to the market's expansion over the forecast period, reinforcing its growth trajectory.
Such advancements in product innovation and clinical validation are expected to enhance the adoption of urinary catheters, thereby creating substantial growth opportunities for market players over the forecast period.
However, despite these growth drivers, the market faces certain challenges. The risk of catheter-associated urinary tract infections (CAUTI) and the availability of alternative treatment options for urinary incontinence are anticipated to act as potential restraints, potentially limiting the market's growth trajectory during the forecast period.
Europe Urinary Catheters Market Trends
Indwelling (Foley) Catheters Segment is Expected to Witness a Positive Growth Over the Forecast Period
An indwelling catheter or Foley catheter is a common type of catheter with a soft, plastic, or rubber tube inserted into the bladder to drain the urine. These are mainly utilized during urinary incontinence (leakage), urinary retention (inability to urinate), etc. The indwelling catheters segment is expected to witness significant growth in Europe due to the increase in bladder and bowel diseases and the rise in demand for Foley catheters due to its advancements.
For instance, as per the Spanish Network of Cancer Registries report published in 2024, 44.29 thousand colorectum cancer cases were diagnosed in 2024 in Spain, which was an increase from 42.72 thousand cases in 2023. Hence, a high prevalence of rectum and colon cancer cases in European countries like Spain is anticipated to raise the demand for Foley catheters and contribute to segment growth over the forecast period.
Furthermore, an increase in research studies demonstrating the advantage of Foley catheters is expected to drive segment growth over the forecast period. For instance, according to an article published by a researcher from Germany in June 2024 in BMC Urology journal, the researcher's analysis revealed that residents hospitalized had a higher likelihood of being catheterized using indwelling catheters. Thus, due to the emergence of such research studies, the demand for Foley catheters is likely to rise, thereby driving segment growth over the forecast period.
Innovative advancements in indwelling catheters, particularly their applications in addressing urinary complications, present substantial growth opportunities for the segment. For instance, a September 2024 article in the European Urology Focus journal highlighted researchers' emphasis on redesigning foley catheters to prevent UTIs. These design modifications aim to minimize undrained urine accumulation, mitigate potential urinary tract trauma, and reduce bacterial adherence. Such advancements not only enhance patient outcomes but also drive demand for improved catheter designs, creating lucrative opportunities for manufacturers to expand their product portfolios and strengthen their market presence.
Thus, owing to the rise in research studies regarding the benefits of Foley catheters and the high prevalence of rectum and colon cancer cases in Europe, the studied segment is expected to witness significant growth over the forecast period.

United Kingdom is Expected to Witness a Significant Growth Over the Forecast Period
United Kingdom (UK) is expected to witness significant market growth owing to the well-established research and development(R&D) infrastructure, a rise in urinary incontinence issues, an increase in investment in R&D by the government, and the presence of key market players. For instance, according to the June 2024 update by the Urology Foundation, according to estimates from the NHS, 14 million individuals in the UK grapple with bladder issues, translating to 1 in 5 people annually. Those facing urinary incontinence often contend with feelings of isolation, especially when their condition hinders their desired lifestyle, leading to embarrassment and challenges in intimacy. Thus, owing to the high prevalence of urinary incontinence cases in the UK, the demand for urinary catheters will likely rise and contribute to market growth.
In the UK, the implementation of targeted awareness campaigns and educational programs is significantly contributing to the growth of the urinary catheters market. These initiatives aim to inform the population about the critical importance of effectively addressing urinary incontinence. For instance, in June 2024, The Urology Foundation, in collaboration with Convatc, organized World Continence Week. This annual event serves as a strategic platform to raise awareness about incontinence-related issues, thereby fostering greater public understanding and encouraging the adoption of treatment solutions. Thus, owing to such initiatives that increase awareness and treatment regarding urinary issues are expected to drive market growth in the United Kingdom over the forecast period.
Furthermore, a significant increase in strategic initiatives targeting the management of urinary complications is anticipated to propel the segment's growth during the forecast period. For instance, in April 2024, Ingenion Medical successfully obtained the CE Mark for its advanced cymactive 2.0R indwelling catheter, specifically engineered to replicate natural urination. This innovative product is designed with a strong focus on enhancing patient outcomes and comfort, positioning itself as a more effective and patient-centric solution compared to traditional Foley-type catheters and intermittent catheters.
Moreover, in July 2024, Convatec, a company specializing in medical products and technologies, launched GentleCath Air for Women, incorporating FeelClean Technology, in the UK and Italy. This strategic expansion followed the product's successful introduction in France, demonstrating the company's commitment to addressing the needs of women requiring advanced catheter solutions. Convatec plans to further strengthen its market presence by launching the product in the United States in September 2024, aiming to capitalize on the growing demand for innovative medical devices in the region. These efforts align with the company's broader strategy to expand its footprint in key global markets and drive sustainable growth through product innovation and customer-centric solutions.
Hence, due to the increase in urinary incontinence issues, a rise in grants, and an increase in awareness campaigns, the United Kingdom is expected to witness significant growth over the forecast period.

Europe Urinary Catheters Industry Overview
The Europe urinary catheters market is semi-consolidated in nature due to the presence of several companies operating globally as well as regionally. Key companies are engaging in strategic activities, such as mergers, acquisitions, partnerships, and product innovations. These initiatives are not only intensifying competition but are also creating avenues for market expansion and diversification. As a result, the market is expected to witness significant growth opportunities in the coming years. A few of the major companies in the market are B Braun SE, Coloplast Corp, Hollister Incorporated, Bactiguard AB, and Convatec Inc.
Europe Urinary Catheters Market Leaders
-
Coloplast Corp
-
B. Braun SE
-
Hollister Incorporated
-
Bactiguard AB
-
Convatec Inc.
- *Disclaimer: Major Players sorted in no particular order

Europe Urinary Catheters Market News
- December 2024: Convatec, a prominent player in medical products and technologies, broadened its me+ programme in the UK, aiming to assist both intermittent catheter users and healthcare professionals (HCPs) for a more seamless cathing experience. This initiative reflects Convatec's commitment to enhancing patient outcomes and supporting healthcare providers by delivering tailored solutions that improve the overall quality of care.
- May 2024: Coloplast enhanced its Luja portfolio by introducing a next-generation catheter designed specifically for women. The female intermittent catheter facilitates complete bladder emptying in a single flow to minimize the risk of urinary tract infections.
Europe Urinary Catheters Industry Segmentation
As per the scope of the report, urinary catheters refer to a long, hollow, flexible tube needed for emptying the bladder and collecting the urine in a drainage bag. The material of the tube can be rubber, plastic, or silicone. If the bladder is not emptied, pressure is created in the kidney tissues, which, under severe conditions, may lead to kidney failure.
The Europe urinary catheters market is segmented by technology, application, and geography. the report offers the value (in USD) for the above segments. By technology, the market is segmented into Indwelling (Foley) Catheters, Intermittent Catheters, External Catheters. By application, the market is segmented into Benign Prostate Hyperplasia (BPH), Urinary Incontinence, Spinal Cord Injury, Other Applications. Other applications include Acute urinary retention or obstruction. By geography, the market is segmented into Germany, United Kingdom, France, Italy, Spain, Rest of Europe. The report offers the value (in USD) for the above segments. The report also covers the estimated market sizes and trends for 5 countries across major European regions. The report offers the value (in USD) for the above segments.
By Technology | Indwelling (Foley) Catheters |
Intermittent Catheters | |
External Catheters | |
By Application | Benign Prostate Hyperplasia (BPH) |
Urinary Incontinence | |
Spinal Cord Injury | |
Other Applications (Acute urinary retention, and Urinary obstruction, Among Others) | |
Geography | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe |
Europe Urinary Catheters Market Research FAQs
How big is the Europe Urinary Catheters Market?
The Europe Urinary Catheters Market size is expected to reach USD 1.33 billion in 2025 and grow at a CAGR of 5.35% to reach USD 1.73 billion by 2030.
What is the current Europe Urinary Catheters Market size?
In 2025, the Europe Urinary Catheters Market size is expected to reach USD 1.33 billion.
Who are the key players in Europe Urinary Catheters Market?
Coloplast Corp, B. Braun SE, Hollister Incorporated, Bactiguard AB and Convatec Inc. are the major companies operating in the Europe Urinary Catheters Market.
What years does this Europe Urinary Catheters Market cover, and what was the market size in 2024?
In 2024, the Europe Urinary Catheters Market size was estimated at USD 1.26 billion. The report covers the Europe Urinary Catheters Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Urinary Catheters Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.